Interview
Video

Beyond the Data: Top Cardiology Trials of 2022

December 12, 2022

23:45

Mamas Mamas sits down with Dipti Itchhaporia and Nick Curzen to discuss standout cardiology research of the year gone by.

mamas Mamas
Dipti Itchhaporia
Nick Curzen
Interview

Recommended Videos

University of Washington Medical Center, Seattle, WA - Balloon Expandable TMVR in Severe MAC sp SEASAME Procedure 42:51

University of Washington Medical Center, Seattle, WA - Balloon Expandable TMVR in Severe MAC sp SEASAME Procedure

Honor Health Medical Center, Scottsdale, AZ - Mitral TEER in Secondary MR 42:40

Honor Health Medical Center, Scottsdale, AZ - Mitral TEER in Secondary MR

Cedars Sinai Medical Center, Los Angeles, CA - Mitral TEER in Primary MR (PRIMARY Trial) 47:20

Cedars Sinai Medical Center, Los Angeles, CA - Mitral TEER in Primary MR (PRIMARY Trial)

University Hospital of Cologne, Department of Cardiology, Cologne, Germany - A Novel Transcatheter Tricuspid Valve Replacement for TR 43:41

University Hospital of Cologne, Department of Cardiology, Cologne, Germany - A Novel Transcatheter Tricuspid Valve Replacement for TR

Cedars Sinai Medical Center, Los Angeles, CA - ViV – Balloon Expandable TMVR 46:02

Cedars Sinai Medical Center, Los Angeles, CA - ViV – Balloon Expandable TMVR

Scripps ClinicScripps Memorial Hospital La Jolla, CA - Complex PCI – Calcified Coronary Treatment 42:48

Scripps ClinicScripps Memorial Hospital La Jolla, CA - Complex PCI – Calcified Coronary Treatment

Saint Luke’s Mid America Heart Institute, Kansas City, MO - Complex Coronary PCI (MVD) and Ischemic Cardiomyopathy 46:00

Saint Luke’s Mid America Heart Institute, Kansas City, MO - Complex Coronary PCI (MVD) and Ischemic Cardiomyopathy

AHA 2023 Wrap-Up 08:45

AHA 2023 Wrap-Up

Lead Management in Patients with Tricuspid Regurgitation and CIEDs 21:27

Lead Management in Patients with Tricuspid Regurgitation and CIEDs

Antiplatelet Decision Making in High-Risk PCI 00:43

Antiplatelet Decision Making in High-Risk PCI

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve 12:49

DurAVR™: Early safety and feasibility of a new class of biomimetic transcatheter aortic valve

Beyond the Data: ORBITA-2 16:33

Beyond the Data: ORBITA-2

Beyond the Data: DAPA-MI 21:07

Beyond the Data: DAPA-MI

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis 05:36

Beyond Echocardiograms: Benefits of Cardiac MRI in Valvular Disease Diagnosis

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study 03:12

Bigger Than You Think: The Unmet Need in Aortic Regurgitation and Key Learnings from the ALIGN-AR Study

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial 42:51

An Examination of TAVR for Aortic Regurgitation: Takeaways from the ALIGN-AR Trial

Interview

See All (366)
Beyond the Data: ORBITA-2 16:33
AHA 2023

Beyond the Data: ORBITA-2

Beyond the Data: DAPA-MI 21:07
AHA 2023

Beyond the Data: DAPA-MI

Beyond the Data: The T-PASS Trial 12:05
TCT 2023

Beyond the Data: The T-PASS Trial

On Record: Out With ABIM, In With a CV Board 10:43
TCT 2023

On Record: Out With ABIM, In With a CV Board

Beyond the Data: Tricuspid Valve Interventions 09:36
TCT 2023

Beyond the Data: Tricuspid Valve Interventions

Beyond the Data: The WATCH-TAVR Trial 14:57
TCT 2023

Beyond the Data: The WATCH-TAVR Trial

Beyond the Data: Aortic Stenosis in the Frail Patient 10:35

Beyond the Data: Aortic Stenosis in the Frail Patient

Beyond the Data: Removing Barriers in Structural Heart Care 10:18
TCT 2023

Beyond the Data: Removing Barriers in Structural Heart Care